|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 489 for Zfp36

0.03s
Type Details Score
GXD Expression  
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1869223
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1666821
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1666827
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1647021
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1647027
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression  
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1647017
Pattern: Not Specified
Stage: TS17
Assay Id: MGI:3509172
Age: embryonic day 10.5
Image: 1
Note: Authors stated that in some instances they could not determine expression levels with certainty.
Specimen Label: 1
Specimen Num: 1
GXD Expression  
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:3185821
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Note: Expression was low or absent.
Specimen Label: 1
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3185827
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:2762123
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
GXD Expression  
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Present
Sex: Male
Emaps: EMAPS:1797223
Pattern: Not Specified
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:1832123
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:2851823
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1754021
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1754027
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:2760523
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
GXD Expression  
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3280927
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Note: The tissue was olfactory epithelium and/or bulb.
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3267921
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3267927
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:2852723
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757721
Stage: TS21
Assay Id: MGI:3508000
Age: embryonic day 13.5
Image: 1
Specimen Label: 1
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2004-12-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757727
Stage: TS27
Assay Id: MGI:3508000
Age: postnatal newborn
Image: 2
Specimen Label: 2
Detected: false
Specimen Num: 2
GXD Expression    
Probe: MGI:3506481
Assay Type: RNA in situ
Annotation Date: 2014-02-07
Strength: Absent
Sex: Male
Emaps: EMAPS:2850023
Stage: TS23
Assay Id: MGI:5539485
Age: embryonic day 15.5
Image: GUDMAP:5811
Specimen Label: GUDMAP:5811
Detected: false
Specimen Num: 1
Publication
First Author: Lee JY
Year: 1998
Journal: DNA Cell Biol
Title: Cloning and characterization of a novel zinc finger protein that associates with nuclear matrix.
Volume: 17
Issue: 10
Pages: 849-58
Publication
First Author: Ebner F
Year: 2017
Journal: J Clin Invest
Title: The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection.
Volume: 127
Issue: 6
Pages: 2051-2065
Publication  
First Author: Kratochvill F
Year: 2011
Journal: Mol Syst Biol
Title: Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation.
Volume: 7
Pages: 560
Publication  
First Author: Choudhary I
Year: 2020
Journal: Front Immunol
Title: Tristetraprolin Overexpression in Non-hematopoietic Cells Protects Against Acute Lung Injury in Mice.
Volume: 11
Pages: 2164
Publication  
First Author: Kwack KH
Year: 2022
Journal: Front Immunol
Title: Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.
Volume: 13
Pages: 1002163
Publication
First Author: Qiu LQ
Year: 2012
Journal: J Immunol
Title: Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype.
Volume: 188
Issue: 10
Pages: 5150-9
Publication
First Author: Smallie T
Year: 2015
Journal: J Immunol
Title: Dual-Specificity Phosphatase 1 and Tristetraprolin Cooperate To Regulate Macrophage Responses to Lipopolysaccharide.
Volume: 195
Issue: 1
Pages: 277-88
Publication
First Author: Al-Haj L
Year: 2012
Journal: Nucleic Acids Res
Title: Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements.
Volume: 40
Issue: 16
Pages: 7739-52
Publication  
First Author: Sawicki KT
Year: 2018
Journal: JCI Insight
Title: Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21.
Volume: 3
Issue: 13
Publication
First Author: Joe Y
Year: 2020
Journal: Cell Rep
Title: Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis.
Volume: 30
Issue: 4
Pages: 1063-1076.e5
Publication  
First Author: Shen TH
Year: 2022
Journal: JCI Insight
Title: Snapshots of nascent RNA reveal cell- and stimulus-specific responses to acute kidney injury.
Volume: 7
Issue: 6
Publication  
First Author: Choi EK
Year: 2018
Journal: Mol Cell Endocrinol
Title: Impaired insulin signaling upon loss of ovarian function is associated with a reduction of tristetraprolin and an increased stabilization of chemokine in adipose tissue.
Volume: 461
Pages: 122-131
Publication
First Author: Petkau G
Year: 2024
Journal: Eur J Immunol
Title: Zfp36l1 establishes the high-affinity CD8 T-cell response by directly linking TCR affinity to cytokine sensing.
Volume: 54
Issue: 2
Pages: e2350700
Publication
First Author: Yamasaki S
Year: 2007
Journal: J Biol Chem
Title: T-cell intracellular antigen-1 (TIA-1)-induced translational silencing promotes the decay of selected mRNAs.
Volume: 282
Issue: 41
Pages: 30070-7
Publication
First Author: Ogilvie RL
Year: 2009
Journal: J Biol Chem
Title: Tristetraprolin mediates interferon-gamma mRNA decay.
Volume: 284
Issue: 17
Pages: 11216-23
Publication
First Author: Phillips K
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis.
Volume: 101
Issue: 7
Pages: 2011-6
Publication
First Author: Qian X
Year: 2011
Journal: J Immunol
Title: Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.
Volume: 186
Issue: 11
Pages: 6454-64
Publication
First Author: Wu X
Year: 2018
Journal: PLoS Genet
Title: The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.
Volume: 14
Issue: 5
Pages: e1007366
Publication
First Author: Lai WS
Year: 2000
Journal: J Biol Chem
Title: Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA.
Volume: 275
Issue: 23
Pages: 17827-37
Publication
First Author: Ma F
Year: 2010
Journal: J Immunol
Title: MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation.
Volume: 184
Issue: 11
Pages: 6053-9
Publication
First Author: Blackshear PJ
Year: 2005
Journal: Biol Reprod
Title: Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins.
Volume: 73
Issue: 2
Pages: 297-307
Publication
First Author: Guo J
Year: 2020
Journal: Cell Death Dis
Title: RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
Volume: 11
Issue: 6
Pages: 413
Publication
First Author: Kang JG
Year: 2011
Journal: J Immunol
Title: Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation.
Volume: 187
Issue: 5
Pages: 2696-701
Publication
First Author: Gaba A
Year: 2012
Journal: J Immunol
Title: Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production.
Volume: 189
Issue: 5
Pages: 2089-93
Publication
First Author: Bollmann F
Year: 2014
Journal: J Biol Chem
Title: Endothelial dysfunction in tristetraprolin-deficient mice is not caused by enhanced tumor necrosis factor-α expression.
Volume: 289
Issue: 22
Pages: 15653-65
Publication
First Author: Alexopoulou L
Year: 2006
Journal: Eur J Immunol
Title: Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity.
Volume: 36
Issue: 10
Pages: 2768-80
Publication
First Author: Wang Q
Year: 2017
Journal: Nat Commun
Title: Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.
Volume: 8
Issue: 1
Pages: 867
Publication
First Author: Iqbal MB
Year: 2014
Journal: Blood
Title: PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression.
Volume: 124
Issue: 24
Pages: 3646-55
Publication
First Author: Ghosh S
Year: 2010
Journal: Am J Pathol
Title: Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha.
Volume: 176
Issue: 3
Pages: 1484-93
Publication
First Author: Chen X
Year: 2012
Journal: Biochem Biophys Res Commun
Title: Role of RNA-binding protein tristetraprolin in tumor necrosis factor-α mediated gene expression.
Volume: 428
Issue: 3
Pages: 327-32
Publication
First Author: Joe Y
Year: 2014
Journal: PLoS One
Title: Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSS-induced colitis.
Volume: 9
Issue: 2
Pages: e88776
Publication  
First Author: O'Neil JD
Year: 2017
Journal: Mol Cell Biol
Title: Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophages In Vitro yet Has Overwhelmingly Anti-Inflammatory Consequences In Vivo.
Volume: 37
Issue: 11
Publication
First Author: Denny P
Year: 2003
Journal: Mamm Genome
Title: A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.
Volume: 14
Issue: 7
Pages: 448-53
Publication
First Author: Chen CY
Year: 2001
Journal: Cell
Title: AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.
Volume: 107
Issue: 4
Pages: 451-64
Publication
First Author: Frasca D
Year: 2007
Journal: J Immunol
Title: Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA.
Volume: 179
Issue: 2
Pages: 918-27
Publication
First Author: Mattijssen S
Year: 2015
Journal: Mol Cell Biol
Title: LARP4 Is Regulated by Tumor Necrosis Factor Alpha in a Tristetraprolin-Dependent Manner.
Volume: 36
Issue: 4
Pages: 574-84
Publication
First Author: Yin K
Year: 2013
Journal: Acta Pharmacol Sin
Title: Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.
Volume: 34
Issue: 6
Pages: 837-46
Publication
First Author: Keeney DS
Year: 1998
Journal: Genomics
Title: The novel skin-specific cytochrome P450 Cyp2b19 maps to proximal chromosome 7 in the mouse, near a cluster of Cyp2 family genes.
Volume: 53
Issue: 3
Pages: 417-9
Publication
First Author: Liang J
Year: 2008
Journal: PLoS One
Title: Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation.
Volume: 3
Issue: 8
Pages: e2880
Publication
First Author: Patial S
Year: 2016
Journal: Mol Cell Biol
Title: Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic Transcriptome.
Volume: 36
Issue: 9
Pages: 1395-411
Publication
First Author: Rounbehler RJ
Year: 2012
Journal: Cell
Title: Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.
Volume: 150
Issue: 3
Pages: 563-74
Publication
First Author: MacKenzie KF
Year: 2013
Journal: Mol Cell Biol
Title: MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.
Volume: 33
Issue: 7
Pages: 1456-67
Publication  
First Author: Sneezum L
Year: 2020
Journal: Front Immunol
Title: Context-Dependent IL-1 mRNA-Destabilization by TTP Prevents Dysregulation of Immune Homeostasis Under Steady State Conditions.
Volume: 11
Pages: 1398
Publication
First Author: Ronkina N
Year: 2019
Journal: J Immunol
Title: The Role of TTP Phosphorylation in the Regulation of Inflammatory Cytokine Production by MK2/3.
Volume: 203
Issue: 8
Pages: 2291-2300
Publication
First Author: Suzuki K
Year: 2003
Journal: J Exp Med
Title: IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells.
Volume: 198
Issue: 11
Pages: 1717-27
Publication
First Author: Tudor C
Year: 2009
Journal: FEBS Lett
Title: The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages.
Volume: 583
Issue: 12
Pages: 1933-8
Publication
First Author: Johnson BA
Year: 2002
Journal: Oncogene
Title: Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways.
Volume: 21
Issue: 27
Pages: 4237-46
Publication
First Author: Chang X
Year: 2007
Journal: Mol Cell Biol
Title: Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor.
Volume: 27
Issue: 17
Pages: 6127-39
Publication
First Author: Liang J
Year: 2009
Journal: J Biol Chem
Title: RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling.
Volume: 284
Issue: 43
Pages: 29383-90
Publication
First Author: Pfeiffer JR
Year: 2012
Journal: J Immunol
Title: Cullin 4B is recruited to tristetraprolin-containing messenger ribonucleoproteins and regulates TNF-α mRNA polysome loading.
Volume: 188
Issue: 4
Pages: 1828-39
Publication
First Author: Bayeva M
Year: 2012
Journal: Cell Metab
Title: mTOR regulates cellular iron homeostasis through tristetraprolin.
Volume: 16
Issue: 5
Pages: 645-57
Publication
First Author: Dai XY
Year: 2014
Journal: Cardiovasc Res
Title: Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Volume: 101
Issue: 2
Pages: 297-305
Publication
First Author: Stumpo DJ
Year: 2016
Journal: Development
Title: Deficiency of the placenta- and yolk sac-specific tristetraprolin family member ZFP36L3 identifies likely mRNA targets and an unexpected link to placental iron metabolism.
Volume: 143
Issue: 8
Pages: 1424-33
Publication
First Author: Coelho MA
Year: 2017
Journal: Immunity
Title: Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Volume: 47
Issue: 6
Pages: 1083-1099.e6
Publication
First Author: Molle C
Year: 2013
Journal: J Exp Med
Title: Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease.
Volume: 210
Issue: 9
Pages: 1675-84
Publication
First Author: Carballo E
Year: 2001
Journal: Blood
Title: Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome.
Volume: 98
Issue: 8
Pages: 2389-95
Publication
First Author: Kontoyiannis D
Year: 2001
Journal: EMBO J
Title: Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.
Volume: 20
Issue: 14
Pages: 3760-70
Publication
First Author: Katsanou V
Year: 2005
Journal: Mol Cell
Title: HuR as a negative posttranscriptional modulator in inflammation.
Volume: 19
Issue: 6
Pages: 777-89
Publication
First Author: Kratochvill F
Year: 2015
Journal: Cancer Res
Title: Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.
Volume: 75
Issue: 15
Pages: 3054-64
Publication
First Author: Schaljo B
Year: 2009
Journal: J Immunol
Title: Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10.
Volume: 183
Issue: 2
Pages: 1197-206
Publication
First Author: Ciais D
Year: 2004
Journal: Oncogene
Title: Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.
Volume: 23
Issue: 53
Pages: 8673-80
Publication
First Author: Tippetts MT
Year: 1988
Journal: Mol Cell Biol
Title: Tumor promoter-inducible genes are differentially expressed in the developing mouse.
Volume: 8
Issue: 10
Pages: 4570-2
Publication
First Author: Deleault KM
Year: 2008
Journal: Mol Immunol
Title: Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Volume: 45
Issue: 1
Pages: 13-24
Publication
First Author: Kusumi K
Year: 1998
Journal: Nat Genet
Title: The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries.
Volume: 19
Issue: 3
Pages: 274-8
Publication
First Author: Zhao C
Year: 2014
Journal: J Immunol
Title: Cellular stress amplifies TLR3/4-induced CXCL1/2 gene transcription in mononuclear phagocytes via RIPK1.
Volume: 193
Issue: 2
Pages: 879-88
Publication
First Author: Dintilhac A
Year: 2002
Journal: J Biol Chem
Title: HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences.
Volume: 277
Issue: 9
Pages: 7021-8
Publication
First Author: Jaradat SA
Year: 1998
Journal: Genomics
Title: Tissue-specific expression and mapping of the Cox7ah gene in mouse.
Volume: 49
Issue: 3
Pages: 363-70
Publication
First Author: Li J
Year: 1999
Journal: Nat Genet
Title: Leukaemia disease genes: large-scale cloning and pathway predictions.
Volume: 23
Issue: 3
Pages: 348-53
Publication
First Author: Chalupnikova K
Year: 2014
Journal: Cell Cycle
Title: An oocyte-specific ELAVL2 isoform is a translational repressor ablated from meiotically competent antral oocytes.
Volume: 13
Issue: 7
Pages: 1187-200
Publication
First Author: Repetto E
Year: 2012
Journal: PLoS Genet
Title: Let-7b/c enhance the stability of a tissue-specific mRNA during mammalian organogenesis as part of a feedback loop involving KSRP.
Volume: 8
Issue: 7
Pages: e1002823
Publication
First Author: Chu VT
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.
Volume: 113
Issue: 44
Pages: 12514-12519
Publication
First Author: Petzold KM
Year: 2013
Journal: Development
Title: Rho signalling restriction by the RhoGAP Stard13 integrates growth and morphogenesis in the pancreas.
Volume: 140
Issue: 1
Pages: 126-35
Publication
First Author: Pei L
Year: 2011
Journal: Nat Med
Title: Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome.
Volume: 17
Issue: 11
Pages: 1466-72
Publication  
First Author: Nechiporuk T
Year: 2016
Journal: Elife
Title: The REST remodeling complex protects genomic integrity during embryonic neurogenesis.
Volume: 5
Pages: e09584
Publication
First Author: Kawai J
Year: 2001
Journal: Nature
Title: Functional annotation of a full-length mouse cDNA collection.
Volume: 409
Issue: 6821
Pages: 685-90
Publication
First Author: Okazaki Y
Year: 2002
Journal: Nature
Title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Volume: 420
Issue: 6915
Pages: 563-73
Publication      
First Author: Shanghai Model Organisms Center
Year: 2017
Journal: MGI Direct Data Submission
Title: Information obtained from the Shanghai Model Organisms Center (SMOC), Shanghai, China
Publication
First Author: Brady KP
Year: 1997
Journal: Genome Res
Title: Genetic mapping of 262 loci derived from expressed sequences in a murine interspecific cross using single-strand conformational polymorphism analysis.
Volume: 7
Issue: 11
Pages: 1085-93